Literature DB >> 16932617

Early aggressive therapy in rheumatoid arthritis: a 'window of opportunity'?

Tom W J Huizinga1, Robert B M Landewé.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16932617     DOI: 10.1038/ncprheum0015

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN: 1745-8382


× No keyword cloud information.
  6 in total

Review 1.  Comparative effectiveness research with administrative health data in rheumatoid arthritis.

Authors:  Marie Hudson; Koray Tascilar; Samy Suissa
Journal:  Nat Rev Rheumatol       Date:  2016-04-15       Impact factor: 20.543

2.  Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?

Authors:  James Woodburn; Kym Hennessy; Martijn Pm Steultjens; Iain B McInnes; Deborah E Turner
Journal:  J Foot Ankle Res       Date:  2010-05-17       Impact factor: 2.303

3.  Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.

Authors:  Hannah Poulsom; Peter J Charles
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

4.  Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI).

Authors:  Anthony Balducci; Brooke M Helfer; Eric T Ahrens; Charles F O'Hanlon; Amy K Wesa
Journal:  J Inflamm (Lond)       Date:  2012-06-21       Impact factor: 4.981

5.  Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies.

Authors:  Tracey M Farragher; Mark Lunt; Darren Plant; Diane K Bunn; Anne Barton; Deborah P M Symmons
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-05       Impact factor: 4.794

6.  A 9 mRNAs-based diagnostic signature for rheumatoid arthritis by integrating bioinformatic analysis and machine-learning.

Authors:  Jianyong Liu; Ningjie Chen
Journal:  J Orthop Surg Res       Date:  2021-01-11       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.